Report 41: “Twenty-Two Cases of Rare Myocarditis by February 2021, Yet Pfizer Said No “New Safety Issues.” FDA Waits Until June 25, 2021, to Include Myocarditis Risk in Fact Sheets.”
August 1, 2026 • by Team 1 physician (Edited by Chris Flowers, MD, and Amy Kelly) – Team 1
![]()
